Chim.Bo
CHIM.BO operates in the Medical Equipment, Supplies & Distribution industry, providing healthcare services and equipment to its customers.
Business. CHIM.BO operates in the Medical Equipment, Supplies & Distribution industry, providing healthcare services and equipment to its customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
CHIM.BO operates in the Medical Equipment, Supplies & Distribution industry, providing healthcare services and equipment to its customers.
CHIM.BO maintains a strong liquidity position, with a current ratio of 4.61, indicating the company can easily cover its short-term liabilities with its current assets. The company holds INR 99.9 million in cash and equivalents, which is a significant portion of its total assets of INR 471.8 million. The liquidity_fpt metric confirms that the company is not under immediate liquidity pressure, with a low risk rating assigned.
In terms of profitability, CHIM.BO generates a return on equity (ROE) of 8.4% and a return on assets (ROA) of 6.57%. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and capital returns. The company's operating income of INR 36.2 million and net income of INR 30.99 million reflect a healthy margin, although the gross profit of INR 65.29 million suggests that cost management remains a key area of focus.
CHIM.BO's revenue is not segmented by geographic region or product line in the available data, but the company's exposure is likely concentrated within its core healthcare services and equipment offerings. The absence of detailed geographic or segment breakdowns limits the ability to assess diversification risk, but the company's overall revenue of INR 369.82 million provides a baseline for evaluating growth potential.
Looking ahead, CHIM.BO is expected to maintain a stable growth trajectory, with no significant revenue deltas projected for the current or next fiscal year. The company's capital expenditures of INR 8.26 million and free cash flow of INR 24.57 million suggest a balanced approach to reinvestment and cash generation. The absence of dilution risk and low liquidity concerns further supports a conservative outlook.
The risk assessment for CHIM.BO indicates a low probability of dilution and no immediate liquidity issues. The company's debt-to-equity ratio of 0.13 is well below the industry median, and its capital structure is supported by a strong equity base of INR 368.79 million. The risk assessment also notes no filing-based flags for liquidity or dilution, reinforcing the company's financial stability.
Recent filings and transcripts do not highlight any material events or strategic shifts for CHIM.BO. The company appears to be operating within a stable regulatory and market environment, with no disclosed risks that would significantly impact its financial performance in the near term.
- CHIM.BO maintains a strong liquidity position with a current ratio of 4.61 and INR 99.9 million in cash and equivalents.
- The company's ROE of 8.4% and ROA of 6.57% indicate solid profitability and asset efficiency.
- CHIM.BO's capital structure is conservative, with a low debt-to-equity ratio of 0.13 and no immediate dilution or liquidity risks.
- The company is expected to maintain a stable growth trajectory with no significant revenue deltas projected.
- No recent filings or transcripts indicate material changes in strategy or risk exposure.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- CHIM.BO Market data — financials · 2026-05-27